3-amino-6-methyl-5-phenyl-2(1h)-pyridinone has been researched along with quazinone in 1 studies
Studies (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Trials (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Recent Studies (post-2010) (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Studies (quazinone) | Trials (quazinone) | Recent Studies (post-2010) (quazinone) |
---|---|---|---|---|---|
11 | 0 | 0 | 42 | 2 | 13 |
Protein | Taxonomy | 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone (IC50) | quazinone (IC50) |
---|---|---|---|
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.24 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erhardt, PW | 1 |
1 review(s) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and quazinone
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |